Skip to main content

School of Pharmacy

Summer camps at WVU provide many opportunities for youth to explore

Summer camp season at West Virginia University begins in May and offers many options for young people to engage both academically and physically during their summer break. Summer camps are known for providing a safe environment where children gain self-confidence as they learn new skills.

Fentanyl deaths up 122 percent in West Virginia, say WVU researchers

West Virginia ranks first for fentanyl-related deaths, but it also leads the nation in a more optimistic way: its medical examiners pinpoint the cause of every drug-related death, and the relevant facts populate a unique statewide database. An interdisciplinary research team—involving the WVU School of Pharmacy, the WVU School of Public Health and the West Virginia Office of the Chief Medical Examiner—analyzed data and found that fentanyl deaths are up 122 percent in the state.

WVU Board begins process to extend President Gee’s contract

The West Virginia University Board of Governors began the process Friday of a state-mandated periodic evaluation of President Gordon Gee, and also set guidelines for a possible renewal of his contract beyond its June 30, 2021 expiration.

WVU grad student pursues drug to treat aggressive form of blood cancer

Osama Elzamzamy, a doctoral student in the West Virginia University School of Medicine, is researching a new drug for use when multiple myeloma just won’t leave a patient alone. He is part of WVU’s doctoral program in clinical and translational science.

NIH awards WVU $11.2 million for interdisciplinary cancer research

West Virginia University’s School of Pharmacy will soon become one of the few pharmacy schools in the nation that leads a center of biomedical research excellence. Funded by the National Institutes of Health, these centers support interdisciplinary, thematically related research into preventing, diagnosing and treating health problems.

WVU researchers working to stop cancer-growth protein

What do one in five breast cancers have in common? Large amounts of a protein called HER2 (or human epidermal growth factor receptor 2). “Every healthy cell produces a normal amount of HER2, but HER2 is produced 10 to 20 times more in a cancer cell,” said Yehenew Agazie, an associate professor of biochemistry at the West Virginia University School of Medicine.